Teva Pharma (TEVA) Announces Nationwide Opioids Settlement

Go back to Teva Pharma (TEVA) Announces Nationwide Opioids Settlement

Teva Announces Nationwide Opioids Settlement to Move Forward After Receiving Broad Support from States

January 9, 2023 8:00 AM EST

TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)-- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today confirmed a sufficient level of participation to move forward with its nationwide settlement agreement to resolve opioid-related claims and litigation by states, cities, counties, and other subdivisions in the United States. Teva has either already settled with or confirmed participation from 48 of the 50 states and will continue to pursue participation by those states that have yet to join. The sign-on process for the states subdivisions will now... More